Does GOLIMUMAB Cause Maternal exposure timing unspecified? 262 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 262 reports of Maternal exposure timing unspecified have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.4% of all adverse event reports for GOLIMUMAB.
262
Reports of Maternal exposure timing unspecified with GOLIMUMAB
0.4%
of all GOLIMUMAB reports
168
Deaths
190
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From GOLIMUMAB?
Of the 262 reports, 168 (64.1%) resulted in death, 190 (72.5%) required hospitalization, and 181 (69.1%) were considered life-threatening.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 262 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which GOLIMUMAB Alternatives Have Lower Maternal exposure timing unspecified Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN